<SEC-DOCUMENT>0001213900-25-039303-index.html : 20250502 <SEC-HEADER>0001213900-25-039303.hdr.sgml : 20250502 <ACCEPTANCE-DATETIME>20250502171147 ACCESSION NUMBER: 0001213900-25-039303 CONFORMED SUBMISSION TYPE: F-3 PUBLIC DOCUMENT COUNT: 11 FILED AS OF DATE: 20250502 DATE AS OF CHANGE: 20250502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enlivex Therapeutics Ltd. CENTRAL INDEX KEY: 0001596812 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-286956 FILM NUMBER: 25909886 BUSINESS ADDRESS: STREET 1: 37 DEREH MENACHEM BEGIN ST. STREET 2: 15TH FLOOR CITY: TEL AVIV STATE: L3 ZIP: 6522042 BUSINESS PHONE: 972 (0) 3 7326616 MAIL ADDRESS: STREET 1: 37 DEREH MENACHEM BEGIN ST. STREET 2: 15TH FLOOR CITY: TEL AVIV STATE: L3 ZIP: 6522042 FORMER COMPANY: FORMER CONFORMED NAME: Bioblast Pharma Ltd. DATE OF NAME CHANGE: 20160919 FORMER COMPANY: FORMER CONFORMED NAME: BIO BLAST PHARMA LTD. DATE OF NAME CHANGE: 20140113 </SEC-HEADER> <DOCUMENT> <TYPE>F-3 <SEQUENCE>1 <FILENAME>ea0240501-f3_enlivex.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: ea0240501-f3_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ea024050101ex5-1_enlivex.htm <DESCRIPTION>OPINION OF FISCHER (FBC & CO.) <TEXT> Document 2 - file: ea024050101ex5-1_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.2 <SEQUENCE>3 <FILENAME>ea024050101ex5-2_enlivex.htm <DESCRIPTION>OPINION OF GREENBERG TRAURIG, P.A. <TEXT> Document 3 - file: ea024050101ex5-2_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>ea024050101ex23-1_enlivex.htm <DESCRIPTION>CONSENT OF YAREL + PARTNERS, INDEPENDENT REGISTERED CERTIFIED PUBLIC ACCOUNTING FIRM <TEXT> Document 4 - file: ea024050101ex23-1_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>ea024050101ex-fee_enlivex.htm <DESCRIPTION>FILING FEE TABLE <TEXT> Document 5 - file: ea024050101ex-fee_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: image_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ex5-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: ex5-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex5-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: ex5-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ex23-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: ex23-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>ex23-1_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: ex23-1_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>ex23-1_003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: ex23-1_003.jpg
</DOCUMENT> </SEC-DOCUMENT>